~5-10% price hike to be implemented across product portfolio. S Chand's 1Q performance was impacted by delay in the start of academic session amid emergence of 2nd wave. As most states are eyeing a staggered re-opening around August/Sep, some revenue spill-over is expected in subsequent quarters. If the upcoming sales season is not impacted by 3 rd wave, revenue can be in the region of Rs5bn in FY22 aided by price hike of ~5-10%. After having managed a successful turnaround in FY21 (break-even...